[MCEMENT] YoY Annualized Quarter Result on 31-Dec-2006 [#4]

Stock
[MCEMENT] MALAYAN CEMENT BERHAD
Announcement Date
16-Feb-2007
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2006
Quarter
31-Dec-2006 [#4]
Profit Trend
QoQ- 30.0%
YoY- 486.27%
Quarter Report
Latest QR
Upcoming QR
MCEMENT's Result
MCEMENT's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 CAGR
Revenue 2,483,106 2,530,771 2,173,532 2,077,893 1,866,668 1,761,555 1,747,997 6.01%
PBT 441,914 397,772 318,134 211,968 29,345 103,693 156,210 18.90%
Tax -35,699 -31,554 -33,443 -38,635 1,956 -20,918 -37,234 -0.69%
NP 406,215 366,218 284,691 173,333 31,301 82,775 118,976 22.68%
-
NP to SH 412,228 367,684 288,147 174,661 29,792 82,775 118,976 22.98%
-
Tax Rate 8.08% 7.93% 10.51% 18.23% -6.67% 20.17% 23.84% -
Total Cost 2,076,891 2,164,553 1,888,841 1,904,560 1,835,367 1,678,780 1,629,021 4.12%
-
Net Worth 3,195,829 3,031,482 4,224,840 3,297,814 3,306,912 1,998,017 2,026,355 7.88%
Dividend
31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 CAGR
Div 322,982 254,746 247,066 84,559 59,584 78,493 57,895 33.14%
Div Payout % 78.35% 69.28% 85.74% 48.41% 200.00% 94.83% 48.66% -
Equity
31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 CAGR
Net Worth 3,195,829 3,031,482 4,224,840 3,297,814 3,306,912 1,998,017 2,026,355 7.88%
NOSH 849,954 849,154 856,359 2,818,645 2,979,200 2,854,310 2,894,793 -18.45%
Ratio Analysis
31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 CAGR
NP Margin 16.36% 14.47% 13.10% 8.34% 1.68% 4.70% 6.81% -
ROE 12.90% 12.13% 6.82% 5.30% 0.90% 4.14% 5.87% -
Per Share
31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 CAGR
RPS 292.15 298.03 175.95 73.72 62.66 61.72 60.38 30.02%
EPS 48.50 43.30 21.00 12.30 1.00 2.90 4.11 50.82%
DPS 38.00 30.00 20.00 3.00 2.00 2.75 2.00 63.27%
NAPS 3.76 3.57 3.42 1.17 1.11 0.70 0.70 32.30%
Adjusted Per Share Value based on latest NOSH - 2,845,884
31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 CAGR
RPS 185.66 189.22 162.51 155.36 139.57 131.71 130.69 6.02%
EPS 30.82 27.49 21.54 13.06 2.23 6.19 8.90 22.97%
DPS 24.15 19.05 18.47 6.32 4.45 5.87 4.33 33.13%
NAPS 2.3895 2.2666 3.1588 2.4657 2.4725 1.4939 1.5151 7.88%
Price Multiplier on Financial Quarter End Date
31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 CAGR
Date 31/12/09 31/12/08 31/12/07 29/12/06 30/12/05 31/12/04 31/12/03 -
Price 6.25 3.94 5.85 4.60 2.05 2.43 3.00 -
P/RPS 2.14 1.32 3.32 6.24 3.27 3.94 4.97 -13.09%
P/EPS 12.89 9.10 25.08 74.23 205.00 83.79 72.99 -25.07%
EY 7.76 10.99 3.99 1.35 0.49 1.19 1.37 33.47%
DY 6.08 7.61 3.42 0.65 0.98 1.13 0.67 44.37%
P/NAPS 1.66 1.10 1.71 3.93 1.85 3.47 4.29 -14.62%
Price Multiplier on Announcement Date
31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 CAGR
Date 25/02/10 18/02/09 27/02/08 16/02/07 23/02/06 28/02/05 24/02/04 -
Price 6.30 3.86 5.60 5.67 2.52 2.77 3.53 -
P/RPS 2.16 1.30 3.18 7.69 4.02 4.49 5.85 -15.28%
P/EPS 12.99 8.91 24.01 91.50 252.00 95.52 85.89 -26.98%
EY 7.70 11.22 4.17 1.09 0.40 1.05 1.16 37.05%
DY 6.03 7.77 3.57 0.53 0.79 0.99 0.57 48.11%
P/NAPS 1.68 1.08 1.64 4.85 2.27 3.96 5.04 -16.71%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment